Stay updated on Immuno-Therapy in Newly Diagnosed GBM Clinical Trial
Sign up to get notified when there's something new on the Immuno-Therapy in Newly Diagnosed GBM Clinical Trial page.

Latest updates to the Immuno-Therapy in Newly Diagnosed GBM Clinical Trial page
- ChecktodayNo Change Detected
- Check7 days agoChange DetectedA banner about NIH’s terminology transition from “Artificial Intelligence” to “Super Intelligence” and related updates is no longer displayed.SummaryDifference1%

- Check14 days agoChange DetectedThe footer revision changed from v3.7.2 to v3.8.0. The page continues to show a 403 Forbidden error instead of the study record.SummaryDifference0.2%

- Check21 days agoChange DetectedA site-wide notice announces NIH’s transition from using “Artificial Intelligence” to “Super Intelligence” terminology and links to related updates and FAQs.SummaryDifference1%

- Check28 days agoChange DetectedThe footer revision identifier changed from v3.7.1 to v3.7.2 on the 403 Forbidden page.SummaryDifference0.2%

- Check35 days agoChange DetectedThe footer now lists site revision v3.7.1 instead of v3.7.0.SummaryDifference0.2%

- Check56 days agoChange DetectedThe study page now renders a 403 Forbidden error, replacing the usual study record content and navigation and making the trial details inaccessible.SummaryDifference18%

Stay in the know with updates to Immuno-Therapy in Newly Diagnosed GBM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Immuno-Therapy in Newly Diagnosed GBM Clinical Trial page.